Scientists test gene injection to turn tumors against themselves
NCT ID NCT01397708
Summary
This early-stage study tested a new two-part treatment for advanced melanoma that cannot be surgically removed. The treatment involved injecting a modified virus directly into tumors to deliver a gene that may help the immune system fight cancer, combined with an oral pill to activate it. The main goal was to check the safety and side effects of this approach in a small group of 26 patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlantic Melanoma Center
Morristown, New Jersey, 07960, United States
-
Fletcher Allen Health
Burlington, Vermont, 05401, United States
-
Indiana University Health Goshen Center for Cancer Care
Goshen, Indiana, 46526, United States
-
James Graham Brown Cancer Center
Louisville, Kentucky, 40202, United States
-
Mary Crowley Cancer Research Center
Dallas, Texas, 75201, United States
-
Oncology Specialists
Park Ridge, Illinois, 60068, United States
-
St. Lukes
Easton, Pennsylvania, 15232, United States
-
The Angeles Clinic
Los Angeles, California, 90404, United States
-
Washington University
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.